Type 1 Diabetes BDCP Clinical Study - Rocky Mountain Clinical Research

Type of Study:
Type 1 diabetes patients who are over 18 years of age

Study Length:
31 Weeks

Target Age/Sex:
over 18 years, Male and Female

Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures

Staus: Enrolling

Description:

The BDCP clinical study is for type 1 diabetes patients, 18 years or older, to evaluate the safety of LY3209590 in patients being treated with multiple daily injection therapy.

Enroll Now

If you are human, leave this field blank.

First Name

Last Name

Phone

Address

City

State/Province

Zip/Postal

Name of Primary Care Physician *

If you don't have a primary care physician, just type "Do not have a primary care physician"

Study Name *